For the last eight years, Mr. Hurvitz has served as Chairman of Teva's Board of Directors.

Previously, he had served as Teva's President and Chief Executive Officer for over 25 years.

 

Under Eli Hurvitz's strategic leadership, and by adopting and internalizing a corporate culture of excellence, Teva became the largest pharmaceutical company in Israel, and the global leader in generic pharmaceuticals.

 

Dr. Phillip Frost, formerly Vice Chairman of the Board, was elected Chairman following Mr. Hurvitz's departure from the Board.

 

Eli Hurvitz passed away on November 21, 2011, at the age of 79.